First Mercantile Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,300
Closed -$445K 1019
2015
Q3
$445K Sell
10,300
-2,100
-17% -$88.6K 0.04% 481
2015
Q2
$524K Sell
12,400
-346
-3% -$14.6K 0.04% 493
2015
Q1
$494K Sell
12,746
-9
-0.1% -$347 0.04% 502
2014
Q4
$430K Sell
12,755
-267
-2% -$9.43K 0.04% 545
2014
Q3
$456K Buy
13,022
+34
+0.3% +$1.17K 0.04% 549
2014
Q2
$426K Buy
12,988
+12,334
+1,886% +$422K 0.03% 556
2014
Q1
$24K Sell
654
-88
-12% -$3.23K ﹤0.01% 1168
2013
Q4
$28K Sell
742
-159
-18% -$5.02K ﹤0.01% 1066
2013
Q3
$25K Buy
901
+46
+5% +$1.09K ﹤0.01% 1067
2013
Q2
$18K Buy
+855
New +$16.7K ﹤0.01% 1081

Other funds holding WX

First Mercantile Trust's WX Position: Q4 2015 in Review

First Mercantile Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,300 shares — an estimated $445K sold.

First Mercantile Trust first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $524K in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • First Mercantile Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • First Mercantile Trust sold 10,300 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $445K.
  • First Mercantile Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • First Mercantile Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $524K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on First Mercantile Trust's 13F filing for Q4 2015, filed 1 Feb 2016.